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THE EFFECTS OF THE RATE OF REOXYGENATION ON THE RECOVERY OF 
HYPOXEMIC HEARTS 
Antonio Corno, MD, a Michele Samaja, PhD, b Stefania Casalini, PhD, b and Sonia Allibardi, PhD, c Milan, Italy 
The myocardial damage induced by the "reoxygenation 
phenomenon" of hypoxic hearts is well known from both 
14 5 experimental - and clinical reports. The surgical repair 
of cyanotic congenital heart defects in infants may be 
complicated by the problem of acute reoxygenation at the 
beginning of cardiopulmonary b pass (CPB). 5 In fact, at 
the onset of CPB the whole body and, therefore, the 
myocardium are suddenly perfused from the arterial ine 
with an oxygen saturation and an oxygen tension (Po2) 
(generally >200 mm Hg) substantially higher than the 
baseline value because of the underlying cyanotic ongen- 
ital heart defect. The main responsibility for the heart 
injury has been clinically associated with the burst of 
oxygen-derived free radicals when cyanotic hearts are 
suddenly exposed to high oxygen pressures. 5 
To test the hypothesis that the rate of reoxygenation 
may be critical in the observed pattern, we performed an 
experimental study in which isolated rat hearts were 
exposed to acute hypoxia and then underwent either 
"fast" or "slow" reoxygenation: the recovery of ventricular 
performance was then compared with the mode of the 
reoxygenation. Isolated rat hearts, perfused with Krebs- 
Henseleit buffer with a coronary flow of 15 ml/min, 3after 
a period of stabilization with 100% oxygen saturation, 
were exposed to 20 minutes of hypoxic perfusion (coro- 
nary flow of 15 ml/min, oxygen saturation 10% of base- 
line). Reoxygenation was either "fast" (Poe increase >200 
mm Hg/sec) or "slow" (Po 2 increase 2 mm Hg/sec). 
The results (Table I) indicate that both the systolic and 
diastolic ventricular functions were more depressed after 
"fast" reoxygenation than after "slow" reoxygenation. 
Although it is difficult to transfer esults gathered in an 
isolated heart preparation to an in vivo situation, from this 
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Table I 
p 
Fast Value Slow 
n 5 5 
Rate of reoxygenation (mm Hg/sec) 200 2 
Recovery (% of baseline) 
Developed pressure 46 ± 7 0.1 62 --- 5 
+dP/dt 48 + 5 0.005 70 _+ 3 
-dP/dt 48 --- 10 NS 61 ± 4 
Oxygen uptake 57 - 8 NS 68 ± 9 
Change over baseline 
End-diastolic pressure (mm Hg) 40 _ 9 0.09 22 _+ 3 
Coronary pressure (ram Hg) 37 ± 18 NS 28 ± 7 
dP/dt, Rate of pressure rise; NS, not significant. 
experimental study it appears that (1) gradual reoxygen- 
ation after hypoxia may contribute to the reduction of 
myocardial injury in infants with cyanosis who undergo 
cardiac repair with the use of CPB; (2) the persisting 
myocardial dysfunction after reoxygenation u derlines the 
presence of factors responsible for the reoxygenation 
damage other than oxygen free radicals3; (3) the bulk of 
the injury may be associated with events that occur not 
only during the reoxygenation, but most likely also during 
hypoxia, such as the high energy demand4; and (4) other 
experimental nd clinical studies are required to learn 
how to prevent or reduce the reoxygenation phenomenon. 
We are already aware of other centers of pediatric 
cardiac surgical care in which CPB in infants with cyanosis 
is routinely initiated with an arterial Po e (80 to 100 mm 
Hg) lower than that generally used and maintained at a 
relatively lower value (maximum 120 mm Hg) than that 
conventionally used (Pedro Del Nido, personal communi- 
cation, 1994). 
REFERENCES 
1. Guarnieri C, Flamigni F, Caldarera CM. Role of 
oxygen in the cellular damage induced by reoxygen- 
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 109, Number 6 
ation of hypoxemic hearts. J Mol Cell Cardiol 1980;12: 
797-808. 
2. Corno A, Samaja M. The reoxygenation phenomenon 
[Letter]. J THOaAC CARDIGVASC SURG 1993;105:373. 
3. Samaja M, Motterlini R, Santoro F, Dell'Antonio G, 
Corno A. Oxidative injury in reoxygenated and reper- 
fused hearts. Free Radic Biol Med 1994;16:255-62. 
Brief communications 1 2 5 1 
4. Samaja M, Casalini S, Allibardi S, Corno A. Effects of 
energy demand in ischemic and hypoxemic isolated rat 
hearts. Adv Exp Med Biol 1994 (In press). 
5. Del Nido P, Mickle DAG, Wilson GJ, et al. Inadequate 
myocardial protection with cold cardioplegic arrest 
during repair of tetralogy of Fallot. J THORAC CARDIO- 
VASC SURG 1988;95:223-9. 
IMPACT OF NITRIC OXIDE INHALATION ON RIGHT VENTRICULAR FAILURE AFTER 
IMPLANTATION OF NOVACOR LEFT VENTRICULAR ASSIST SYSTEM 
Paul Michel Mertes, MD, Georges Pinelli, MD, Thierry Hubert, MD, Jean Pierre Carteaux, MD, 
Etienne Hottier, MD, Alain Larcan, MD, and Jean Pierre Villemot, MD, Nancy, France 
The left ventricular assist system (LVAS) (Baxter Health- 
care Corporation, Novacor Division, Oakland, Calif.) used 
as a bridge in the expectation of transplantation has been 
shown to effectively improve cardiac output even in patients 
with biventricular failure) Nevertheless, many patients till 
require some sort of inotropic support and/or pulmonary 
vasodilator therapy to optimize right ventricular (RV) per- 
formance. Consequently, appropriate selection of potential 
recipients calls for careful evaluation of preimplantation 
pulmonary artery pressure and vascular esistance, which 
should remain in a suitable range to ensure successful heart 
transplantation. However, in certain cases, high pulmonary 
resistance necessitating concomitant RV support has been 
observed. We report here one such case in which an early 
rise in pulmonary artery pressure led to rapid RV failure, 
and the use of inhaled nitric oxide allowed us to forgo the 
need for mechanical RV support. 
A 54-year-old man with dilated idiopathic ardiomyop- 
athy received an LVAS because of repeated episodes of 
left ventricular failure necessitating increasing doses of 
sympathomimetic drugs. This patient was regarded eligi- 
ble for heart ransplantation. The preoperative pulmonary 
vascular resistance was 4 Wood units. After he was 
weaned from cardiopulmonary b pass (CPB), a rapid rise 
in mean pulmonary arterial pressure was observed from 
40 to 65 mm Hg, associated with a decrease in RV ejection 
fraction from 17% to 6% and persistent low pump output 
below 3 L/rain. This reduced pump output was related to 
difficulties in pump filling as witnessed by the reduction in 
LVAS peak filling volume, which precisely monitors this 
phenomenon. This change occurred despite the use of 
isoproterenol (0.1 ~g/kg per minute) and epinephrine (0.2 
p~g/kg per minute) therapy, concomitant with administra- 
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tion of prostacyclin at an increasing rate of 5 to 20 ng/kg 
per minute. After an hour, in the absence of a satisfactory 
hemodynamic response, CPB was reinstituted. Nitric ox- 
ide was then administered as a specific pulmonary vaso- 
dilator therapy in a premixed concentration of 900 ppm 
nitric oxide in nitrogen (CFPO, Paris, France). Nitric 
oxide was introduced into the breathing system circuit 
near the endotracheal tube via a separate flowmeter. The 
nitric oxide flow rate was adjusted to reach a concentra- 
tion of 50 ppm. Almost 30 minutes later, a progressive 
increase in peak LVAS filling volume was noted. CPB was 
then progressively interrupted. At the same time, LVAS 
pump output rapidly increased to 5 L/min, RV function 
improved (ejection fraction 17%), and mean pulmonary 
arterial pressure dropped to 35 mm Hg. The day after, mean 
pulmonary arterial pressure further decreased to 27 mm Hg 
while RV ejection fraction rose to 23%. Inotropic support 
and nitric oxide inhalation were then progressively decreased 
and the patient was extubated after 5 days. 
This observation underscores the possibility afforded by 
nitric oxide inhalation in the reduction of acutely in- 
creased pulmonary vascular esistance after CPB during 
LVAS implantation. 2'3 In our opinion, its feasibility 
should be considered before any decision is made to 
institute RV support in cases of early inadequate LVAS 
system filling. 
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